In this study, using bioinformatics analysis and in vitro assays, we aimed to examine the role of HEXA and HEXB in progression of GBM and whether HEXA and HEXB could serve as potential prognostic biomarkers for GBM, which would lead to the identification of new targets for the treatment of GBM. The gene discussed is HEXA; the disease is glioblastoma.